Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticityThomas C. Westbrook(University of Michigan), Joshi J. Alumkal(University of Michigan)Nature CommunicationsSeptember 15, 202210.1038/s41467-022-32701-6Cited by 59SaveCiteExport RISWatch citationsRelated PapersAntitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study|The Lancet|2010|1.1kLSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function|JCI Insight|2023|40Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer|Scientific Reports|2019|36